Health Catalyst Reports Financial Updates and Guidance Reduction

Health Catalyst, Inc. lowered its full-year 2026 revenue guidance to a midpoint of $247.5 million, representing a 5.7% decrease from its previous forecast. For the upcoming third quarter, the company expects revenue of $55.5 million, marking a significant sequential decline from the $70.49 million reported in the second quarter. While the company's second-quarter adjusted earnings per share met analyst estimates, the updated outlook reflects ongoing challenges for the data and analytics provider. The company's stock has experienced significant volatility and downward pressure throughout the year.